VanEck Associates’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.98M Sell
10,363
-84
-0.8% -$24.1K ﹤0.01% 892
2025
Q1
$3.22M Buy
10,447
+199
+2% +$61.3K ﹤0.01% 867
2024
Q4
$3.62M Sell
10,248
-508
-5% -$179K ﹤0.01% 811
2024
Q3
$3.79M Sell
10,756
-138
-1% -$48.7K ﹤0.01% 746
2024
Q2
$3.47M Buy
10,894
+355
+3% +$113K ﹤0.01% 707
2024
Q1
$2.42M Buy
10,539
+475
+5% +$109K ﹤0.01% 807
2023
Q4
$2.21M Buy
10,064
+379
+4% +$83.3K ﹤0.01% 777
2023
Q3
$2.19M Buy
9,685
+84
+0.9% +$19K ﹤0.01% 731
2023
Q2
$2.12M Buy
9,601
+5,419
+130% +$1.2M ﹤0.01% 715
2023
Q1
$937K Buy
4,182
+2,642
+172% +$592K ﹤0.01% 848
2022
Q4
$428K Buy
1,540
+208
+16% +$57.8K ﹤0.01% 951
2022
Q3
$279K Buy
1,332
+120
+10% +$25.1K ﹤0.01% 981
2022
Q2
$286K Buy
1,212
+136
+13% +$32.1K ﹤0.01% 1006
2022
Q1
$193K Buy
1,076
+148
+16% +$26.5K ﹤0.01% 1104
2021
Q4
$201K Buy
928
+43
+5% +$9.31K ﹤0.01% 1107
2021
Q3
$163K Sell
885
-3,801
-81% -$700K ﹤0.01% 1061
2021
Q2
$841K Buy
4,686
+467
+11% +$83.8K ﹤0.01% 826
2021
Q1
$706K Buy
+4,219
New +$706K ﹤0.01% 794
2020
Q3
Sell
-58,177
Closed -$7.04M 1036
2020
Q2
$7.04M Buy
58,177
+7,985
+16% +$966K 0.02% 301
2020
Q1
$4.76M Sell
50,192
-3,577
-7% -$339K 0.02% 319
2019
Q4
$4.74M Buy
53,769
+4,933
+10% +$435K 0.02% 378
2019
Q3
$3.9M Sell
48,836
-5,512
-10% -$440K 0.02% 372
2019
Q2
$4.24M Sell
54,348
-18,676
-26% -$1.46M 0.02% 360
2019
Q1
$8.57M Sell
73,024
-8,900
-11% -$1.04M 0.04% 235
2018
Q4
$8.92M Sell
81,924
-735
-0.9% -$80K 0.04% 234
2018
Q3
$10.6M Buy
82,659
+1,367
+2% +$175K 0.05% 238
2018
Q2
$9.2M Buy
81,292
+17,203
+27% +$1.95M 0.04% 235
2018
Q1
$7.2M Sell
64,089
-15,294
-19% -$1.72M 0.04% 263
2017
Q4
$11.7M Sell
79,383
-43,717
-36% -$6.47M 0.06% 221
2017
Q3
$14.4M Buy
123,100
+10,598
+9% +$1.24M 0.07% 205
2017
Q2
$14.6M Buy
112,502
+19,120
+20% +$2.48M 0.08% 194
2017
Q1
$12.6M Buy
93,382
+16,540
+22% +$2.24M 0.06% 211
2016
Q4
$11M Sell
76,842
-9,672
-11% -$1.39M 0.05% 208
2016
Q3
$10.2M Sell
86,514
-14,588
-14% -$1.72M 0.05% 210
2016
Q2
$10.7M Sell
101,102
-14,253
-12% -$1.51M 0.05% 197
2016
Q1
$12.9M Sell
115,355
-15,141
-12% -$1.69M 0.09% 153
2015
Q4
$20.4M Buy
130,496
+26,364
+25% +$4.13M 0.16% 129
2015
Q3
$13.7M Sell
104,132
-20,696
-17% -$2.72M 0.11% 159
2015
Q2
$21.7M Buy
124,828
+7,802
+7% +$1.36M 0.13% 142
2015
Q1
$20.2M Sell
117,026
-17,726
-13% -$3.06M 0.12% 146
2014
Q4
$17.4M Buy
134,752
+27,126
+25% +$3.51M 0.11% 148
2014
Q3
$13.8M Sell
107,626
-3,517
-3% -$452K 0.07% 179
2014
Q2
$9.84M Sell
111,143
-26,770
-19% -$2.37M 0.05% 198
2014
Q1
$13M Buy
137,913
+2,859
+2% +$269K 0.06% 178
2013
Q4
$15.3M Buy
135,054
+16,676
+14% +$1.89M 0.08% 148
2013
Q3
$9.33M Buy
118,378
+14,559
+14% +$1.15M 0.05% 183
2013
Q2
$6.83M Buy
+103,819
New +$6.83M 0.04% 194